• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乙醇提取物抑制流感病毒在体外和体内的感染。

Ethanol Extract of Inhibits Influenza Virus Infection In Vitro and In Vivo.

机构信息

State Key Laboratory of Virology, Wuhan Institute of Virology, Chinese Academy of Sciences, Wuhan 100864, Hubei, China.

University of Chinese Academy of Sciences, Beijing 100049, China.

出版信息

Viruses. 2020 May 18;12(5):557. doi: 10.3390/v12050557.

DOI:10.3390/v12050557
PMID:32443510
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7290740/
Abstract

Influenza virus infections can lead to viral pneumonia and acute respiratory distress syndrome in severe cases, causing significant morbidity and mortality and posing a great threat to human health. Because of the diversity of influenza virus strains and drug resistance to the current direct antiviral agents, there have been no effective drugs as yet to cure all patients infected by influenza viruses. Natural products from plants contain compounds with diverse structures that have the potential to interact with multiple host and virus factors. In this study, we identified the ethanol extract of (Roth) Alston (EEC) as an inhibitor against the replication of a panel of influenza A and B viruses both on human pulmonary epithelial A549 and human monocytic U937 cells. The animal study revealed that EEC administration reduces the weight loss and improves the survival rate of mice infected with lethal influenza virus. Also, EEC treatment attenuated lung injury and reduced virus titer significantly. In conclusion, we showed that EEC has antiviral activity both in vitro and in vivo, suggesting that the plant has the potential to be further developed as a resource of new anti-influenza drugs.

摘要

流感病毒感染可导致严重病例的病毒性肺炎和急性呼吸窘迫综合征,造成重大发病率和死亡率,对人类健康构成巨大威胁。由于流感病毒株的多样性和对现有直接抗病毒药物的耐药性,目前尚无有效的药物治愈所有感染流感病毒的患者。植物来源的天然产物含有具有与多种宿主和病毒因素相互作用潜力的多种结构化合物。在这项研究中,我们发现(Roth)Alston 的乙醇提取物(EEC)是一种抑制物,可在人肺上皮 A549 和人单核细胞 U937 细胞上抑制一系列甲型和乙型流感病毒的复制。动物研究表明,EEC 给药可减轻感染致死性流感病毒的小鼠的体重减轻并提高其存活率。此外,EEC 治疗可显著减轻肺损伤并降低病毒滴度。总之,我们表明 EEC 在体外和体内均具有抗病毒活性,这表明该植物有可能进一步开发成为新的抗流感药物资源。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/18468871f83d/viruses-12-00557-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/28914aa85797/viruses-12-00557-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/d933a6f3a582/viruses-12-00557-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/2715581f018b/viruses-12-00557-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/18468871f83d/viruses-12-00557-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/28914aa85797/viruses-12-00557-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/d933a6f3a582/viruses-12-00557-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/2715581f018b/viruses-12-00557-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ea7d/7290740/18468871f83d/viruses-12-00557-g004.jpg

相似文献

1
Ethanol Extract of Inhibits Influenza Virus Infection In Vitro and In Vivo.乙醇提取物抑制流感病毒在体外和体内的感染。
Viruses. 2020 May 18;12(5):557. doi: 10.3390/v12050557.
2
Inhibition of influenza virus replication by plant-derived isoquercetin.植物源异槲皮苷抑制流感病毒复制。
Antiviral Res. 2010 Nov;88(2):227-35. doi: 10.1016/j.antiviral.2010.08.016. Epub 2010 Sep 6.
3
Anti-Influenza Activity of an Ethyl Acetate Fraction of a Ethanol Extract by Neuraminidase Inhibition.乙醇提取物的乙酸乙酯部分通过抑制神经氨酸酶表现出的抗流感活性。
Oxid Med Cell Longev. 2020 Oct 29;2020:8824934. doi: 10.1155/2020/8824934. eCollection 2020.
4
The PA Endonuclease Inhibitor RO-7 Protects Mice from Lethal Challenge with Influenza A or B Viruses.PA核酸内切酶抑制剂RO-7可保护小鼠免受甲型或乙型流感病毒的致死性攻击。
Antimicrob Agents Chemother. 2017 Apr 24;61(5). doi: 10.1128/AAC.02460-16. Print 2017 May.
5
In vitro anti-influenza viral activities of constituents from Caesalpinia sappan.苏木成分的体外抗流感病毒活性
Planta Med. 2009 Mar;75(4):337-9. doi: 10.1055/s-0028-1112208. Epub 2009 Jan 15.
6
A pharmacologically immunosuppressed mouse model for assessing influenza B virus pathogenicity and oseltamivir treatment.一种评估乙型流感病毒致病性和奥司他韦治疗效果的药理学免疫抑制小鼠模型。
Antiviral Res. 2017 Dec;148:20-31. doi: 10.1016/j.antiviral.2017.10.021. Epub 2017 Oct 31.
7
Homoisoflavonoids from Caesalpinia sappan displaying viral neuraminidases inhibition.金莲花中的异黄酮类化合物抑制病毒神经氨酸酶。
Biol Pharm Bull. 2012;35(5):786-90. doi: 10.1248/bpb.35.786.
8
Liu Shen Wan inhibits influenza a virus and excessive virus-induced inflammatory response via suppression of TLR4/NF-κB signaling pathway in vitro and in vivo.Liu Shen Wan 通过抑制 TLR4/NF-κB 信号通路抑制甲型流感病毒和过度病毒诱导的炎症反应,在体内外。
J Ethnopharmacol. 2020 Apr 24;252:112584. doi: 10.1016/j.jep.2020.112584. Epub 2020 Jan 21.
9
Oral administration of a prodrug of the influenza virus neuraminidase inhibitor GS 4071 protects mice and ferrets against influenza infection.口服流感病毒神经氨酸酶抑制剂GS 4071的前体药物可保护小鼠和雪貂免受流感感染。
Antimicrob Agents Chemother. 1998 Mar;42(3):640-6. doi: 10.1128/AAC.42.3.640.
10
Coadministration of Hedera helix L. Extract Enabled Mice to Overcome Insufficient Protection against Influenza A/PR/8 Virus Infection under Suboptimal Treatment with Oseltamivir.常春藤提取物与奥司他韦联合使用,可使小鼠在奥司他韦治疗效果欠佳的情况下,克服对甲型流感病毒A/PR/8感染的防护不足。
PLoS One. 2015 Jun 22;10(6):e0131089. doi: 10.1371/journal.pone.0131089. eCollection 2015.

引用本文的文献

1
Enhanced anti-influenza activity of fermented yellow soybean extract and daidzein co-treatment on MDCK cells.发酵黄豆提取物与大豆苷元联合处理对MDCK细胞的抗流感活性增强
Food Sci Biotechnol. 2024 Aug 20;34(3):733-742. doi: 10.1007/s10068-024-01673-2. eCollection 2025 Feb.
2
Green solvent-based extraction of three Fabaceae species: A potential antioxidant, anti-diabetic, and anti-leishmanial agents.基于绿色溶剂的三种豆科植物提取:潜在的抗氧化、抗糖尿病和抗利什曼原虫剂。
Heliyon. 2024 Jun 26;10(13):e33668. doi: 10.1016/j.heliyon.2024.e33668. eCollection 2024 Jul 15.
3
In Vitro Anti-Influenza Virus Activity of Non-Polar subsp. Extract.

本文引用的文献

1
The Establishment and Validation of the Human U937 Cell Line as a Cellular Model to Screen Immunomodulatory Agents Regulating Cytokine Release Induced by Influenza Virus Infection.建立和验证人 U937 细胞系作为一种细胞模型,用于筛选调节流感病毒感染诱导的细胞因子释放的免疫调节剂。
Virol Sin. 2019 Dec;34(6):648-661. doi: 10.1007/s12250-019-00145-w. Epub 2019 Jul 8.
2
A small-molecule fusion inhibitor of influenza virus is orally active in mice.小分子流感病毒融合抑制剂在小鼠体内具有口服活性。
Science. 2019 Mar 8;363(6431). doi: 10.1126/science.aar6221.
3
The human antibody response to influenza A virus infection and vaccination.
非极性亚种提取物的体外抗流感病毒活性
Pharmaceuticals (Basel). 2022 Dec 5;15(12):1513. doi: 10.3390/ph15121513.
4
Identification of Protosappanoside D from and Evaluation of Its Pharmacokinetic, Metabolism and Pharmacological Activity.从 中鉴定Protosappanoside D 及其药代动力学、代谢和药理学活性评价。
Molecules. 2022 Sep 18;27(18):6090. doi: 10.3390/molecules27186090.
5
Plant-Based Natural Products and Extracts: Potential Source to Develop New Antiviral Drug Candidates.植物源天然产物和提取物:开发新型抗病毒药物候选物的潜在来源。
Molecules. 2021 Oct 14;26(20):6197. doi: 10.3390/molecules26206197.
6
Bioactive Natural Antivirals: An Updated Review of the Available Plants and Isolated Molecules.生物活性天然抗病毒药物:现有植物和分离分子的最新综述。
Molecules. 2020 Oct 22;25(21):4878. doi: 10.3390/molecules25214878.
人体对甲型流感病毒感染和疫苗接种的抗体反应。
Nat Rev Immunol. 2019 Jun;19(6):383-397. doi: 10.1038/s41577-019-0143-6.
4
Current and future influenza vaccines.当前和未来的流感疫苗。
Nat Med. 2019 Feb;25(2):212-220. doi: 10.1038/s41591-018-0340-z. Epub 2019 Jan 28.
5
Tissue tropisms opt for transmissible reassortants during avian and swine influenza A virus co-infection in swine.在禽源和猪源甲型流感病毒共感染猪体的过程中,组织嗜性有利于可传播的重配体。
PLoS Pathog. 2018 Dec 3;14(12):e1007417. doi: 10.1371/journal.ppat.1007417. eCollection 2018 Dec.
6
Baloxavir Marboxil for Uncomplicated Influenza in Adults and Adolescents.巴洛沙韦玛波西利治疗成人和青少年单纯性流感。
N Engl J Med. 2018 Sep 6;379(10):913-923. doi: 10.1056/NEJMoa1716197.
7
Influenza.流感。
Nat Rev Dis Primers. 2018 Jun 28;4(1):3. doi: 10.1038/s41572-018-0002-y.
8
Characterization of influenza virus variants induced by treatment with the endonuclease inhibitor baloxavir marboxil.描述使用内切酶抑制剂巴洛沙韦治疗诱导的流感病毒变异体。
Sci Rep. 2018 Jun 25;8(1):9633. doi: 10.1038/s41598-018-27890-4.
9
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.全球季节性流感相关呼吸道死亡率的估计:一项建模研究。
Lancet. 2018 Mar 31;391(10127):1285-1300. doi: 10.1016/S0140-6736(17)33293-2. Epub 2017 Dec 14.
10
Influenza.流感。
Lancet. 2017 Aug 12;390(10095):697-708. doi: 10.1016/S0140-6736(17)30129-0. Epub 2017 Mar 13.